Literature DB >> 15991039

Communication of findings in pharmacovigilance: use of the term "signal" and the need for precision in its use.

Manfred Hauben, Lester Reich.   

Abstract

Mesh:

Year:  2005        PMID: 15991039     DOI: 10.1007/s00228-005-0951-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.

Authors:  A R Cox; J F Marriott; K A Wilson; R E Ferner
Journal:  J Clin Pharm Ther       Date:  2004-02       Impact factor: 2.512

2.  Assessing the impact of drug safety signals from the WHO database presented in 'SIGNAL': results from a questionnaire of National pharmacovigilance Centres.

Authors:  Malin Ståhl; I Ralph Edwards; Geoffrey Bowring; Anne Kiuru; Marie Lindquist
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Comparison of data mining methodologies using Japanese spontaneous reports.

Authors:  Kiyoshi Kubota; Daisuke Koide; Toshiki Hirai
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-06       Impact factor: 2.890

4.  Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms.

Authors:  Manfred Hauben; Lester Reich; Stephanie Chung
Journal:  Eur J Clin Pharmacol       Date:  2004-11-17       Impact factor: 2.953

Review 5.  Principles of signal detection in pharmacovigilance.

Authors:  R H Meyboom; A C Egberts; I R Edwards; Y A Hekster; F H de Koning; F W Gribnau
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

Review 6.  False-positives in spontaneous reporting: should we worry about them?

Authors:  B Begaud; Y Moride; P Tubert-Bitter; A Chaslerie; F Haramburu
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

7.  Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data.

Authors:  D Layton; E Heeley; S A W Shakir
Journal:  J Clin Pharm Ther       Date:  2004-04       Impact factor: 2.512

  7 in total
  14 in total

1.  Data mining in pharmacovigilance: lessons from phantom ships.

Authors:  Manfred Hauben; Lester Reich; Eugène P Van Puijenbroek; Charles M Gerrits; Vaishali K Patadia
Journal:  Eur J Clin Pharmacol       Date:  2006-08-03       Impact factor: 2.953

2.  Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

Authors:  June S Almenoff; Karol K LaCroix; Nancy A Yuen; David Fram; William DuMouchel
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  'Extreme duplication' in the US FDA Adverse Events Reporting System database.

Authors:  Manfred Hauben; Lester Reich; James DeMicco; Katherine Kim
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Extension of points on clarifying terminology in drug safety.

Authors:  Manfred Hauben; Lester Reich; Flic Gabbay
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Design and analysis of post-marketing research.

Authors:  Xiao-Hua Andrew Zhou; Wei Yang
Journal:  Chin J Integr Med       Date:  2013-07-02       Impact factor: 1.978

7.  A Review of Pharmacovigilance.

Authors:  J E Campbell; M Gossell-Williams; M G Lee
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

8.  Defining 'surveillance' in drug safety.

Authors:  Jeffrey K Aronson; Manfred Hauben; Andrew Bate
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

9.  Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.

Authors:  Alice Capogrosso Sansone; Irma Convertino; Maria Teresa Galiulo; Stefano Salvadori; Stefania Pieroni; Tamara Knezevic; Stefania Mantarro; Alessandra Marino; Manfred Hauben; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

10.  Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation.

Authors:  Francesco Salvo; Emanuel Raschi; Ugo Moretti; Anita Chiarolanza; Annie Fourrier-Réglat; Nicholas Moore; Miriam Sturkemboom; Fabrizio De Ponti; Elisabetta Poluzzi; Antoine Pariente
Journal:  Eur J Clin Pharmacol       Date:  2014-03-05       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.